Qiagen NV

NYSE:QGEN   3:59:58 PM EDT
-0.28 (-0.56%)

QIAGEN Adds New Biopharma Products And Launches Expert Custom Assay Design Service

Published: 07/27/2022 05:55 GMT
Qiagen NV (QGEN) - Adds New Biopharma Products to Qiacuity Digital Pcr Portfolio and Launches Expert Custom Assay Design Service.
13 New Kits and Assays Allow for Quantification of Aav Viral Titer and Residual Host Cell Dna in Cell and Gene Therapy.
Milestone Achieved With Over 1,000 Cumulative Placements of Standard-setting Qiacuity Systems.
A New Version of Qiacuity Software Suite Has Been Released With Expanded Functionality to Support Good Manufacturing Practice (gmp) Compliance.